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Cervical Cancer Survival by Socioeconomic Status,
Race/Ethnicity, and Place of Residence in Texas,
1995–2001
KATHERINE S. EGGLESTON, M.S.P.H.,1 ANN L. COKER, Ph.D.,1
MELANIE WILLIAMS, Ph.D.,2 GUILLERMO TORTOLERO-LUNA, M.D., Ph.D.,1
JEANNE B. MARTIN, Ph.D., R.D., F.A.D.A., L.D.,1 and SUSAN R. TORTOLERO, Ph.D.1

ABSTRACT
Objective: The current study explored whether socioeconomic status (SES), race/ethnicity, and
rural residence may be linked to poorer cervical cancer survival by stage at diagnosis.
Methods: Data from 7,237 cervical cancer cases reported to the Texas Cancer Registry from
1995–2001 were used to address the association by stage at diagnosis and cause of death. Zip
code-level census data were used to classify residence and to develop a composite variable
for SES. Multilevel Cox proportional hazards modeling was used to estimate hazard ratios
(HR) and 95% confidence intervals (CI).
Results: Late stage at diagnosis was a strong predictor of cervical cancer mortality (HR 
6.2, 95% CI 5.5-7.2). SES and race/ethnicity were independently associated with stage at diagnosis. Women residing in areas with lower SES had significantly shorter survival times
when diagnosed at an early stage (HR  3.0, 95% CI 2.1-4.3). Hispanic women had a lower
probability of dying from cervical cancer during the follow-up period (HR  0.7, 95% CI 0.60.8) after adjusting for confounders. The association between lower SES and poorer survival
was consistent across all racial/ethnic groups, suggesting the effect of SES may be more important than race
Conclusions: SES and race/ethnicity were independently associated with poorer cervical cancer survival in this large Texas sample. Further research is needed to investigate the role of
optimal treatment and comorbid conditions in the association between SES and cervical cancer survival.
INTRODUCTION

D

of cervical
cancer, an estimated 9710 women will be diagnosed and 3700 of these women will die from
this malignancy in the United States in 2006.1 Hispanic women have the highest age-adjusted cervical cancer incidence, and African American woESPITE THE PREVENTABLE NATURE

men have the highest mortality rates compared
with non-Hispanic whites.1 Differences in socioeconomic status (SES) by race/ethnicity may
explain observed racial differences in cervical
cancer incidence and mortality.
SES is best described as a combination of highly
correlated yet distinct factors, including income,
education, occupation, and place of residence.2

1School
2Texas

of Public Health, University of Texas Health Science Center, Houston, Texas.
Department of State Health Services, Cancer Epidemiology and Surveillance Branch, Austin, Texas.
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Data from these factors are commonly used as
proxy variables to indicate overall SES. Among
studies examining SES indicators and survival,3–11 about one third5–7 found an association
between low SES and poorer cervical cancer survival after adjusting for race/ethnicity. In a large
cohort study, Singh et al.12 found that cervical
cancer mortality increased with increasing
poverty and lower education for women in each
racial/ethnic group examined. Using data from
the Military Healthcare System in which all women had similar access to care, Farley et al.3
found that neither race/ethnicity nor SES were
associated with cervical cancer survival. Almost
half of all studies addressing race/ethnicity and
survival without adjusting for SES9,13–20 concluded that minority race/ethnicity was an important predictor of survival.13,14,16–18 However,
failure to adjust for SES may be responsible for
the apparent racial gap in survival that was observed.
Fewer studies have addressed rural residence
as a proxy measure for access to care and cervical cancer survival.5,21 O’Brien et al.21 found that
women living in rural areas in Australia were at
higher risk of death than those living in metropolitan areas (standardized mortality ratio 10.1),
suggesting lack of access to healthcare services.
In contrast, Johnson5 did not find this association
among South Carolina women after adjusting for
race/ethnicity, age, and poverty (adjusted hazard
ratio [HR]  1.10, 95% confidence interval [CI]
0.81-1.50).
The large population, ethnic diversity, and
high proportion of rural areas make Texas an optimal state to study the impact of socioeconomic
factors on cervical cancer survival. The purpose
of this study is to estimate cervical cancer survival by SES, rural residence, and race/ethnicity
while adjusting for confounders using multilevel
Cox proportional hazards modeling.

MATERIALS AND METHODS
Data for this population-based cohort study
were obtained from the Texas Cancer Registry
(TCR), which has a case completeness proportion
of 99%.22 Institutional Review Boards from the
Texas Department of State Health Services and
the University of Texas Health Science Center
at Houston reviewed the study protocol and
deemed the project exempt. Eligible cases in-

cluded women 18 years reported to the TCR as
having an invasive primary cervical cancer diagnosis between January 1, 1995, and June 30, 2001.
Women with multiple primary cancers were excluded. Incident cases were linked with the Texas
Department of State Health Services mortality
data through December 21, 2001, to identify women with an incident cancer who died, along
with the date and underlying causes of death. All
women in whom cervical cancer was listed as an
underlying cause of death were used to estimate
cause-specific survival rates. Women who died
from other causes were censored.

Exposures: SES, rural residence, and
race/ethnicity
Data from the TCR and the U.S. Census 2000
were used to define three primary exposures:
SES, rural residence, and race/ethnicity. A composite variable was created for SES using ZIP
code-level data for median income, poverty, education, and employment. Poverty was defined
as the percent of residents living in the ZIP code
of the cervical cancer patient whose incomes were
at or below the federal definition of poverty.23
Similarly, low education and unemployment
were defined as the percent of women living in
the ZIP code of the cervical cancer patient with
less than a high school education23 and who were
not in the labor force,24 respectively. As all other
variables comprising the composite variable are
percentages, median income was transformed
into a percent for purposes of consistency. Median income was defined as the percent difference between the median household income of
residents living in the ZIP code of the cervical
cancer patient and the median household income
for the state of Texas.23 The four indicator variables were summed to create the final SES composite variable based on an accepted measure of
community-level SES.25–27 Analysis of the individual components of the composite variable
showed satisfactory internal consistency (Cronbach’s alpha  0.71). Given that the percent difference ranged from negative to positive values
(corresponding to median incomes lesser and
greater than the median income for Texas), the final composite variable was brought to a positive
distribution by adding the absolute value of the
largest negative value to the entire distribution.
SES was then categorized into quartiles based on
the distribution of the data.
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Rural residence was hypothesized to be a proxy
measure for access to healthcare, including proximity to urban areas where cancer screening and
treatment services are more readily available. Rural
residence was also defined using ZIP code-level
data from the U.S. Census 2000, which indicates the
proportion of the ZIP code denoted as rural.28 This
variable was categorized into five groups based on
distribution of the Texas population: urban (0%
rural, referent group), midurban (11.66% rural),
rural (11.67%–23.32% rural), midrural (23.33%–
69.99% rural) and very rural (70% rural).
Race/ethnicity was defined by individual data
from two variables (race and Spanish/Hispanic
origin) abstracted from medical records by TCR
staff. This enabled us to classify those with a
Spanish/Hispanic origin who may report different racial groups. Race/ethnicity was categorized
as white non-Hispanic (referent group), African
American, Hispanic, and other race/ethnicity
groups (Asian, other, and unknown). Of those
classified as Hispanic, 32.3% were Mexican,
57.2% were Spanish, Hispanic, or Latina, 7.2%
had a Spanish surname, 2.6% were other Hispanic, 0.4% were Central or South American,
0.2% were Puerto Rican, and 0.1% were Cuban.
No African American women reported a Spanish/Hispanic origin.

Outcome: Cervical cancer survival
The primary outcome was months of survival
following cervical cancer diagnosis. Subjects were
censored at the end of the follow-up on December 31, 2001. Data characterizing stage at diagnoses were obtained from the TCR and reported
using the Surveillance, Epidemiology and End
Results (SEER) summary staging guide. Stage at
diagnosis was classified into two categories: early
and late stage. Early stage is classified as localized only and corresponds to International Federation of Gynecology and Obstetrics (FIGO)
staging by including stages I, IA1, IA2, and IB.
Late stage is classified as regional or invasive carcinoma and likewise corresponds to FIGO stages
IIA, IIB, IIA, III, and IV.29 Stage of diagnosis was
evaluated as an effect measure modifier because
the impact of poverty, rural residence or race/
ethnicity on survival may differ by stage.

Statistical methods
All data were analyzed using the statistical
software package Intercooled Stata version 8.0.

943

As stage at diagnosis is a strong predictor of survival, we used multivariate logistic regression to
determine if the socioeconomic composite variable, rural residence, and race/ethnicity were associated with late stage at diagnosis. All women
who were missing on stage at diagnosis (n 
1241) were excluded from analyses because of the
strong impact of stage on survival. Potential confounders included age, year of diagnosis, and
cancer cell type.
Multilevel Cox proportional hazards modeling
was used to estimate the relative risk of dying
from cervical cancer associated with SES, rural
residence, and race/ethnicity. The Breslow-Day
test for homogeneity, as a measure of effect modification of stage on SES and survival, was significant (chi-square  7.37, p  0.001); therefore,
all analyses were conducted by stage (early stage
I–IB, late stage IIA–IV). An additional model,
where stage was treated as a confounder, was
also employed. Analyses were conducted for cervical cancer-specific mortality, in which women
dying from other causes were excluded. Survival
curves were generated using the Kaplan-Meier
procedure and compared using the log-rank test.
Although cervical cancer cell type was evaluated
as a potential confounder due to differences in
survival and efficacy of screening among women
with adenocarcinoma, it did not meet the operational definition of a confounder in a cohort
study. All final models included the primary exposures of interest: composite SES, rural residence, race/ethnicity, and age.

RESULTS
Table 1 provides the descriptive characteristics of all 7237 women diagnosed with primary
invasive cervical cancer from January 1, 1995, to
June 30, 2001, and reported to the TCR. Of those
with data on stage at diagnosis, the majority of
patients were diagnosed in the early stage
(59.2%) with squamous cell carcinomas (72%).
The mean age of women diagnosed with cervical cancer was 50.0  16.2 years, with almost
two thirds of women diagnosed before age 55.
Over 30% of women diagnosed with cervical
cancer reported a Spanish/Hispanic origin, and
approximately 14% were African American
(Table 1). Twenty-eight percent (n  2029) of
the cohort died during the follow-up period. Almost 73% of women who died with information
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TABLE 1.

CHARACTERISTICS OF WOMEN DIAGNOSED WITH CERVICAL CANCER AND REPORTED
TEXAS CANCER REGISTRY, JANUARY 1995–JUNE 2001 (n  7237)

TO THE

Characteristic
Age, years
18–34
35–44
45–54
55–64
65
Race/ethnicity
White non-Hispanic
White Hispanic
African American
Other/unknown
Year of diagnosis
1995
1996
1997
1998
1999
2000
2001
SEER staging
Stage IA–IB
Stage IIA–IV
Missing stage
Cell type
Squamous cell
Adenocarcinoma
Rarea
Unknown morphology

Number

%

Cumulative %

1250
1974
1519
971
1523

17.3
27.3
21.0
13.4
21.0

017.3
0044.6
65.6
079.0
100.0

3787
2263
983
204

52.3
31.3
13.6
2.8

052.3
065.9
097.2
100.0

1161
1184
1108
1104
1067
1041
572

16.0
16.4
15.3
15.3
14.7
14.4
7.9

016.0
032.4
047.7
063.0
077.7
092.1
100.0

3595
2473
1169

49.7
34.2
16.1

049.7
083.9
100.0

5249
1343
129
516

72.5
18.6
1.8
7.1

072.5
091.1
092.9
100.0

aThose morphologies included as Rare cell types include sarcoma, carcinosarcoma, spindle cell sarcoma, small cell
sarcoma, large cell carcinoma, leiomyosarcoma, mixoid leiomyosarcoma, embryonal rhabdomyosarcoma, neuroendocrine carcinoma, and large cell neuroendocrine carcinoma.

on stage at diagnosis were diagnosed with late
stage disease.
Table 2 shows the association between the composite SES variable, rural residence, race/ethnicity, and stage of cervical cancer diagnosis. Patients with missing staging information (n 
1169), no available ZIP code data (n  116), and
with other/unknown race/ethnicity (n  162)
were excluded, leaving 5790 women for logistic
regression analysis. After adjusting for race/ethnicity, rural residence, and age, women living in
ZIP codes with lower SES were more likely to be
diagnosed at a later stage. The trend test of
greater proportion late stage with decreasing SES
was significant (p  0.001). Rural residence was
not associated with being diagnosed at a later
stage. Relative to non-Hispanic white women
with cervical cancer, African American and Hispanic women were more likely to be diagnosed
at a later stage (Table 2).

Table 3 and Figures 1 and 2 present the results from the survival analysis. Patients with
missing staging information (n  1169), no
available ZIP code date (n  116), with other/
unknown race/ethnicity (n  162), and listing
competing causes of death (n  323) were excluded, leaving 5467 women for the Cox proportional hazards modeling and Kaplan-Meier
analyses. The demographic profile of women included in the survival analysis was not statistically different from that of women in the full
sample. Kaplan-Meier survival curves (Figs. 1
and 2) limited to early and late stage disease,
respectively, indicate that lower SES is associated with reduced cervical cancer survival time
for women diagnosed in both early (log-rank
test chi-square  35.2, p  0.001) and late stage
disease (log-rank test chi-square  21.1, p value
0.001). Women diagnosed in late stage disease
were 6.2 times (adjusted HR 95% CI 5.5-7.2)
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TABLE 2.

MULTIVARIATE PREDICTORS OF LATE STAGE CERVICAL CANCER DIAGNOSIS
5790a WOMEN REPORTED TO THE TEXAS CANCER REGISTRY, 1995–2001
Late stageb (%)
2377 (41.1)

Number
5790
Composite socioeconomic statusc
Low SES
Medium SES
High SES
Very High SES
Trend test
Rural residencec
70.00% rural
23.33%–69.99% rural
11.67%–23.32% rural
0.01%–11.66% rural
Urban: 0% rural
Trend test
Race/ethnicityc
African American
Hispanic
White non-Hispanic

AMONG

Adjusted OR (95% CI)
n  5790

1442
1445
1443
1460

694
622
553
508

(48.1)
(43.0)
(38.3)
(34.8)

1.4 (1.2–1.7)d
1.2 (1.1–1.5)d
1.1 (1.0–1.3)d
1.0 Refe
Z  4.49; p  0.001d

572
973
553
1576
2116

240
393
221
598
925

(42.0)
(40.4)
(40.0)
(37.9)
(43.7)

(0.8–1.2)d
(0.8–1.1)d
(0.7–1.1)d
(0.7–0.9)d
1.0 Ref
Z  0.6; p  0.55

790
1861
3139

1.0
0.9
0.9
0.8

1.3 (1.1–1.6)d
1.3 (1.1–1.5)d
1.0 Ref

374 (47.3)
838 (45.0)
1165 (37.1)

aWomen

excluded from this analysis include those with no available ZIP code data, those of other/unknown
race/ethnicity, and those with missing stage at diagnosis.
bLate stage includes summary stages IIA–IV.
cOdds ratios are adjusted for age and other covariates in the table.
dp  0.05.
eRef, reference group.

Survival Probability

1.00

0.75

0.50
Log Rank Test = 34.16, p-value < 0.001
0.25

0.00
0

20

40

60

80

Analysis Time (Months)
Very High SES

High SES

Medium SES

Low SES

FIG. 1. Kaplan-Meier survival estimates: Early stage survival of cervical cancer patients by socioeconomic status.
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Survival Probability

1.00

0.75

0.50

0.25
Log Rank Test = 21.72, p-value < 0.001
0.00
0

20

40

60

80

Analysis Time (Months)

FIG. 2.

Very High SES

High SES

Medium SES

Low SES

Kaplan-Meier survival estimates: Late stage survival of cervical cancer patients by socioeconomic status.

more likely to die than women diagnosed with
early stage disease (Table 3).
Lower SES was associated with shorter cervical cancer cause-specific survival time among women with cervical cancer. The trend test for quartiles of the composite SES variable and survival
time supports a dose-dependent association for
both early and late stage at diagnosis (Table 3).
Comparison of the lowest to highest SES quartile
and cervical cancer survival time indicates that
SES is associated with poor survival for both early
and late stage disease (early stage adjusted
aHR  3.0, 95% CI 2.1-4.3; late stage aHR  1.7,
95% CI 1.4-2.1). Moreover, when stage is treated
as a confounder in the model, low SES remains
associated with poor survival (aHR  1.9, 95% CI
1.6-2.3, p for trend 0.001).
Rural residence was not associated with cervical cancer survival in any stage of diagnosis
(Table 3). Furthermore, trend tests do not indicate a dose-dependent relationship between the
degree of rural/urban residence and survival. Increased risk estimates for women living in areas
that are approximately 23%–70% rural are seen
across early, late, and all stages of diagnosis (all
stages, aHR  1.2, 95% CI 1.0-1.4; early stage

aHR  1.2, 95% CI 0.9-1.7; late stage aHR  1.2,
95% CI 1.0-1.5); however, these estimates did not
reach statistical significance.
Race/ethnicity remained associated with survival after adjusting for SES, rural residence, and
age. Relative to non-Hispanic white women,
African American women were 1.3 times (95% CI
1.1-1.5) more likely to die of cervical cancer independent of stage (Table 3). Hispanic women,
however, had a significant survival advantage
(aHR  0.7, 95% CI 0.6-0.8) relative to non-Hispanic white women that held for all stages at diagnosis (Table 3).
Results of this analysis show that both SES
and race/ethnicity affect cervical cancer survival after adjusting for stage at diagnosis and
age. In Table 4, we present analysis of SES and
cervical cancer survival within the three
racial/ethnic groups. SES continued to be associated with cervical cancer survival in each
racial/ethnic group, with the most elevated risk
among Hispanic women living in areas of low
SES (aHR  2.2, 95% CI 1.5-3.3). Moreover,
trend tests reflect a dose-dependent association
between SES and survival within each racial/
ethnic group (Table 4).
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TABLE 3.

MULTIVARIATE PREDICTORS AND RELATIVE CERVICAL CANCER SURVIVALa (COX PROPORTIONAL HAZARDS
MODELING) AMONG 5467b WOMEN REPORTED TO THE TEXAS CANCER REGISTRY, 1995–2001
Death rate
(per 1000
womenmonth)

Composite socioeconomic status in quartiles
Low SES
7.8
Medium SES
7.0
High SES
5.1
Very High SES
3.5
Trend test
Rural residence in quintiles
70.00% rural
6.3
23.33%–69.99% rural
7.0
11.67%–23.32% rural
6.1
0.01%–11.66% rural
4.7
Urban: 0% rural
5.8
Trend test
Race/ethnicity
African American
9.0
Hispanic
4.9
White non-Hispanic
5.6
Stage at diagnosis
Late stage
4.5
Early stage
0.7

Adjusted HR (95% CI)
All stagec
n  5467

Early staged
n  3267

Late staged
n  2200

1.9 (1.6–2.3)*
1.6 (1.4–2.0)*
1.3 (1.1–1.6)*
1.0 Refe
Z  7.6, p  0.001*

3.0 (2.1–4.3)*
2.0 (1.4–2.9)*
1.4 (1.0–2.1)
1.0 Ref
Z  6.5, p  0.001*

1.7 (1.4–2.1)*
1.5 (1.2–1.9)*
1.3 (1.0–1.6)
1.0 Ref
Z  5.3, p  0.001*

1.0 (0.8–1.2)
1.2 (1.0–1.4)
1.1 (0.9–1.3)
0.9 (0.8–1.1)
1.0 Ref
Z  1.6, p  0.01

0.8 (0.5–1.3)
1.2 (0.9–1.7)
1.2 (0.8–1.8)
0.9 (0.6–1.2)
1.0 Ref
Z  0.4, p  0.67

1.1 (0.8–1.3)
1.2 (1.0–1.5)
1.0 (0.8–1.3)
0.9 (0.8–1.1)
1.0 Ref
Z  1.6, p  0.012

1.3 (1.1–1.5)*
0.7 (0.6–0.8)*
1.0 Ref

1.1 (0.8–1.6)
0.7 (0.5–0.9)*
1.0 Ref

1.3 (1.1–1.6)*
0.7 (0.6–0.8)*
1.0 Ref

6.2 (5.5–7.2)
1.0 Ref

1.0 Ref

1.0 Ref

aAnalysis

restricted to those reporting a death due to cervical cancer.
excluded from this analysis include those with no available ZIP code data, those of other/unknown
race/ethnicity, and those with missing stage at diagnosis.
cHRs adjusted for stage, age, and other covariates in the table.
dHRs adjusted for age and other covariates in the table.
eRef, reference group.
*p  0.05.
bWomen

TABLE 4.

SOCIOECONOMIC STATUS AND RELATIVE CERVICAL CANCER SURVIVALa BY RACE/ETHNICITY (COX PROPORTIONAL
HAZARDS MODELING) AMONG 5467b WOMEN REPORTED TO THE TEXAS CANCER REGISTRY, 1995–2001
Adjustedc HR (95% CI)

Composite
socioeconomic status
Low SES
Mid-SES
High SES
Very high SES
Trend test

African American

Hispanic

White non-Hispanic

2.0 (1.3–3.0)*
1.8 (1.1–2.8)*
1.4 (0.8–2.1)*
1.0 Refd
p  0.001

2.2 (1.5–3.3)*
2.0 (1.3–3.0)*
1.3 (0.8–2.0)*
1.0 Ref
p  0.001

1.6 (1.2–2.0)*
1.5 (1.2–1.8)*
1.3 (1.0–1.6)*
1.0 Ref
p  0.001

aAnalysis

restricted to those reporting a death due to cervical cancer.
excluded from this analysis include those with no available ZIP code data, those of other/unknown
race/ethnicity.
cHRs adjusted for age, stage, and rural residence.
dRef, reference group.
*p  0.05.
bWomen

DISCUSSION
Minority race/ethnicity has consistently been
documented as a risk factor for later stage of cervical cancer diagnosis.5,11,12,14,30–36 Our study

found that a lower composite SES and minority
race/ethnicity were associated with late stage at
diagnosis. Additionally, lower SES and African
American race were associated with poorer
survival. Although Hispanic women were more
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likely than non-Hispanic white women to present
help at a later stage, Hispanic cervical cancer patients were less likely to die of this disease. Furthermore, the association between lower SES
and poorer survival was consistent across all
racial/ethnic groups, suggesting the effect of SES
may be more important than race.
Our finding that lower SES was associated
with poorer survival, particularly among those
diagnosed at an early stage, is consistent with
the work reported by Mundt et al.,7 Morgan et
al.,6 and Johnson,5 who found that SES may be
an important predictor of survival after adjusting for race/ethnicity. Further, our findings
concur with those of Singh et al.13 who found
that mortality increased with increasing
poverty for women in all racial/ethnic groups.
Five other studies found no association with
SES after adjusting for age and race/ethnicity4,9–11 or stage of disease.21
The effect of rural residence as a proxy for access to care may differentially affect stage at diagnosis and survival if access to screening services is different from access to follow-up and
treatment services. We report no association between rural residence and stage at diagnosis or
survival, which contrasts with the strong association between rural residence and cervical cancer
mortality (OR  19.4) reported by O’Brien et al.
in Australia.21 However, our findings concur
with those reported by Johnson5 for cervical cancer survival in South Carolina. Results of borderline significance for the association between
women living in areas that are between 27% and
70% rural with reduced survival may indicate a
greater difficulty for these women to receive
treatment services. However, adequate treatment
data are necessary to explore these preliminary
results.
When adjusting for SES, our conclusion that
African American women were more likely to be
diagnosed at a late or unknown stage and to have
shorter survival times, particularly among those
diagnosed at a late or missing stage, is consistent
with the preponderance of the existing literature,4,9,12,13,15,17 yet four studies reported that
African American race was not an important predictor of survival after adjusting for socioeconomic factors.3,5,10,11 Our finding that Hispanic
women were less likely to die of cervical cancer
compared with non-Hispanic white women
within any stage at diagnosis contrasts with the
two published studies with sufficient numbers

EGGLESTON ET AL.

that report Hispanic ethnicity was not an independent predictor of survival.13,30

Strengths and limitations of the study
A limitation to this study is the use of aggregate (census) data as indicators for individual SES
and rural residence. However, defining rural residence by ZIP code is not likely to cause misclassification. Census tract residential conditions
based on the federal definition of rural and urban areas28 are not likely to vary greatly for individuals within a ZIP code. This may not be the
case for ZIP code-level proxies for SES. Census
tract-level data have been used to estimate the potential effects of SES,10,12 yet these data were not
available to us. A recent study by Robert et al.,26
using the same components measures of SES used
here, reported that census tract level variables
were consistent with the effects of SES using ZIP
code-level variables. Our ZIP code-level data may
cause some misclassification relative to census
tract-level data, yet any misclassification will
likely bias the measure of association toward the
null. It is possible, however, that we could have
differential misclassification if lower SES women
were consistently misclassified as higher SES because of their ZIP codes. An analysis of the correlation between the components of our composite SES measure revealed satisfactory correlation
(Cronbachs’ alpha  0.71), thus supporting accurate categorization of women in respective SES
quintiles.
The use of death certificate information to determine cause of death may contribute to outcome misclassification for our cervical cancer survival analysis. This potential for bias is likely to
be nondifferential, as census data are not linked
with vital records. Exclusions for missing data
(e.g., those diagnosed by death certificate only)
may cause selection bias. However, our comparisons between the complete dataset and that used
for analyses did not show statistically significant
differences in the variables of interest.
Using tumor registry or medical record data to
abstract race/ethnicity has the potential for misclassification. However, using data from both the
race and Spanish/Hispanic origin variables increases accurate classification of race/ethnicity.
Accuracy between medical records and self-report has reported to be moderate (Latinas) to high
(whites, Asians, and African Americans).37 Furthermore, the TCR has strict guidelines outlined
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in the Texas cancer reporting handbook for identifying persons of Spanish or Hispanic origin.22
Other intervening variables not measured by
this model that may affect the association between SES factors and mortality include treatment and presence of comorbid illnesses.38 Like
most cancer registries, the TCR was established
to provide a population-based estimate of cancer
incidence, not to provide validated treatment
data. Acquiring information on these variables
from outside sources will help to better understand the relationship between factors associated
with decreased survival from cervical cancer. We
are looking toward future studies that will include data on these variables to supplement the
registry data.
Strengths of this study include its large sample
size (n  7346), which reduces random error and
increases study power. The use of a populationbased cancer registry reduces the potential for selection bias by including all cervical cancer cases
in Texas. Evidence for case completeness includes
the reported TCR completeness proportion of
99% and the similar number of cervical cancer
cases reported per year to the TCR between 1997
and 2001 (1071)39 compared with the American
Cancer Society annual estimate for Texas in 2001
(1000).40

Future directions
Further studies are needed to replicate our finding that Hispanic women with cervical cancer have
better survival relative to non-Hispanic white and
African American women. The well documented
Hispanic paradox41–43 indicates that regardless of
lower SES, the Hispanic population in the United
States has lower mortality rates. Reasons for this
advantage may include difference in social support, religion/faith, cultural influences, or healthselective immigration differences between these
populations. Health-selective return migration of
immigrants may underestimate the mortality rates
in the United States,44 leading to an underascertainment bias in Hispanic mortality rates from research linked to the U.S. Death Index.
To address the possibility that Hispanic women with cervical cancer return to Mexico and
are, therefore, underreported as cases in the TCR,
we restricted the analysis to exclude women with
cervical cancer living along the Texas-Mexico
border (El Paso, Starr, Cameron, Hidalgo, and
Willacy counties). Hispanics relative to non-His-

949

panic white women still had a survival advantage (aHR  0.8, 95% CI 0.7-0.9). This finding indicates that selective migration back to Mexico
may not explain the strong protective effect of
Hispanic ethnicity on cervical cancer survival.
The findings reported here suggest that disadvantaged groups (e.g., African Americans or
people with low SES) may be at higher risk of
dying from a preventable (early stage) cancer.
Additional research on these high-risk groups
is needed to identify the missed opportunities
for preventing death among these women.
Missed opportunities may take the form of logistical/financial barriers (e.g., having no
transportation for treatment, not having insurance, or insurance not covering care), communication barriers (e.g., language barriers between patient and healthcare provider or not
understanding options offered for treatment),
selective provision of healthcare by race/ethnicity, income, or rural residence (e.g., not offering more aggressive treatment to someone
living in rural areas), and individual or cultural
differences in reaction to cervical cancer. As the
effect of SES was shown to be consistent across
all raceial/ethnic groups, interventions may be
more effective in reducing cervical cancer mortality if these are developed to target women of
lower SES rather than by racial/ethnic groups.
Interventions can be developed to target highrisk groups, for example, to ensure that stateof-the-art treatment is offered and resources are
provided to overcome the impact of logistical
or financial barriers.

REFERENCES
1. American Cancer Society. Cancer facts and figures,
2006. Atlanta, GA: ACS, 2005.
2. LaVeist TA. Disentangling race and socioeconomic
status: A key to understanding health inequalities. J
Urban Health 2005;82 (Suppl 3):26.
3. Farley JH, Hines JF, Taylor RR, et al. Equal care ensures equal survival for African American women
with cervical carcinoma. Cancer 2001;91:869.
4. Greenwald HP, Polissar NL, Dayal HH. Race, socioeconomic status and survival in three female cancers.
Ethnic Health 1996;1:65.
5. Johnson MG. Poverty and cervical cancer survival
among South Carolina women. Am J Epidemiol
2004;159:S1.
6. Morgan MA, Behbakht K, Benjamin I, et al. Racial differences in survival from gynecologic cancer. Obstet
Gynecol 1996;88:914.

Hosted in the Center for Research on Violence Against Women institutional repository with written permission from Mary Ann Liebert, publishers.

950
7. Mundt AJ, Connell PP, Campbell T, Hwang JH, Rotmensch J, Waggoner S. Race and clinical outcome in
patients with carcinoma of the uterine cervix treated
with radiation therapy. Gynecol Oncol 1998;71:151.
8. Murphy M, Goldblatt P, Thornton-Jones H, Silcocks
P. Survival among women with cancer of the uterine
cervix: Influence of marital status and social class. J
Epidemiol Community Health 1990;44:293.
9. Samelson EJ, Speers MA, Ferguson R, Bennett C.
Racial differences in cervical cancer mortality in
Chicago. Am J Public Health 1994;84:1007.
10. Schwartz KL, Crossley-May H, Vigneau FD, Brown
K, Banerjee M. Race, socioeconomic status and stage
at diagnosis for five common malignancies. Cancer
Causes Control 2003;14:761.
11. Shelton D, Paturzo D, Flannery J, et al. Race, stage of
disease, and survival with cervical cancer. Ethnic Dis
1992;2:47.
12. Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U.S. Incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 2004;101:1051.
13. Brewster WR, DiSaia PJ, Monk BJ, Ziogas A, Yamada
SD, Anton-Culver H. Young age as a prognostic factor in cervical cancer: Results of a population-based
study. Am J Obstet Gynecol 1999;180:1464.
14. Brooks SE, Baquet CR, Gardner JF, Moses G, Ghosh
A. Cervical cancer—The impact of clinical presentation, health and race on survival. J Assoc Acad Minor
Phys 2000;11:55.
15. Grigsby PW, Hall-Daniels L, Baker S, Perez CA. Comparison of clinical outcome in black and white women treated with radiotherapy for cervical carcinoma.
Gynecol Oncol 2000;79:357.
16. Howell EA, Chen YT, Concato J. Differences in cervical cancer mortality among black and white women.
Obstet Gynecol 1999;94:509.
17. Jones WB, Shingleton HM, Russell A, et al. Patterns
of care for invasive cervical cancer. Results of a national survey, 1984–1990. Cancer 1995;76:1934.
18. Lin SS, Clarke CA, Prehn AW, Glaser SL, West DW,
O’Malley CD. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer
2002;94:1175.
19. Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: Analysis of
seven selected sites. Am J Epidemiol 1991;133:672.
20. Schorge JO, Lea JS, Garner EO, Duska LR, Miller DS,
Coleman RL. Cervical adenocarcinoma survival
among Hispanic and white women: A multicenter cohort study. Am J Obstet Gynecol 2003;188:640.
21. O’Brien ED, Bailie RS, Jelfs PL. Cervical cancer mortality in Australia: Contrasting risk by aboriginality,
age and rurality. Int J Epidemiol 2000;29:813.
22. Texas Department of Health. Cancer reporting laws
and rules. Available at www.tdh.state.tx.us/tcr/rules.html
Accessed January 8, 2004.
23. U. S. Census Bureau. Current population survey—
Definitions and explanations. Available at www.census.

EGGLESTON ET AL.

24.

25.

26.

27.

28.

29.

30.

31.

32.

33.

34.

35.

36.

37.

38.

39.

gov/population/www/cps/cpsdef.html Accessed May 16,
2005.
U. S. Census Bureau. Employment status. Available at
www.census.gov/acs/www/UseData/Def/Employme.htm
Accessed May 16, 2005.
Diez Roux AV, Kiefe CI, Jacobs DR, et al. Area characteristics and individual level socioeconomic position indicators in three population based epidemiologic studies. Ann Epidemiol 2001;11:395.
Robert SA, Strombom I, Tretntham-Dietz A, et al. Socioeconomic risk factors for breast cancer. Distinguishing individual- and community-level effects.
Epidemiology 2004;15:442.
Sanderson M, Coker AL, Perez A, Fadden MK. A multilevel analysis of socioeconomic status and prostate
cancer risk. Ann Epidemiol 2006. Jul 11 (Epub ahead
of print).
U. S. Census Bureau. Urban and rural definitions.
Available at: Available at www.census.gov/population/
censusdata/urdef.txt Accessed June 27, 2005.
Young JL, Roffers SD, Riess LAG, Fritz AG, Hurlbut
AA. SEER summary staging manual—2000: Codes
and coding instructions. Bethesda, MD: National
Cancer Institute, 2001.
Centers for Disease Control and Prevention. Invasive
cervical cancer among Hispanic and non-Hispanic
women—United States, 1992–1999, MMWR 2002;51:
1067.
Breen N, Figueroa JB. Stage of breast and cervical cancer diagnosis in disadvantaged neighborhoods: A
prevention policy perspective. Am J Prev Med
1996;12:319.
Chen F, Trapido EJ, Davis K. Differences in stage at
presentation of breast and gynecologic cancers among
whites, blacks, and Hispanics. Cancer 1994;73:2838.
del Carmen MG, Montz FJ, Bristow RE, Bovicelli A,
Cornelison T, Trimble E. Ethnic differences in patterns
of care of stage 1a(1) and stage 1a(2) cervical cancer:
A SEER database study. Gynecol Oncol 1999;75:113.
Howe SL, Delfino RJ, Taylor TH, Anton-Culver H.
The risk of invasive cervical cancer among Hispanics:
Evidence for targeted preventive interventions. Prev
Med 1998;27:674.
Liu T, Wang X, Waterbor JW, Weiss HL, Soong SJ. Relationships between socioeconomic status and racespecific cervical cancer incidence in the United States,
1973–1992. J Health Care Poor Underserved 1998;9:
420.
Mitchell JBP, McCormack LAM. Time trends in latestage diagnosis of cervical cancer: Differences by
race/ethnicity and income. Med Care 1997;35:1220.
West CN, Geiger AM, Greene SM, et al. Race and ethnicity: Comparing medical records to self-reports. J
Natl Cancer Inst Monogr 2005;35:72.
Coker AL, Du XL, Fang S, Eggleston KE. Socioeconomic status and cervical cancer survival among
older women: Findings from the SEER-Medicare
linked data cohorts. Gynecol Oncol 2006;102:278.
Texas Department of State Health Statistics. Cancer
incidence and mortality rates, 1997–2001. Available at

Hosted in the Center for Research on Violence Against Women institutional repository with written permission from Mary Ann Liebert, publishers.

SOCIOECONOMIC STATUS AND CERVICAL CANCER SURVIVAL

40.
41.

42.

43.

www.tdh.state.tx.us/tcr/DataTables/9710Web/Statewide/9
710bySW-AR.htm Accessed May 9, 2005.
American Cancer Society. Cancer facts and figures,
2001. Atlanta, GA: ACS, 2001.
Hummer RARRGASH. Adult mortality differentials
among Hispanic subgroups and non-Hispanic whites.
Soc Sci Q 2000;81:459.
Liao Y, Cooper RS, Cao G, et al. Mortality patterns
among adult Hispanics: Findings from the NHIS,
1986–1990. Am J Public Health 1998;88:227.
Markides KS, Coreil J. The health of Hispanics in the
southwestern United States: An epidemiologic paradox. Public Health Rep 1986;11:253.

951

44. Patel KV, Eschbach K, Ray LA, Markides KS. Evaluation of mortality data for older Mexican Americans:
Implications for the Hispanic paradox. Am J Epidemiol 2004;159:707.

Address reprint requests to:
Katherine S. Eggleston, MSPH
University of Texas, School of Public Health
1200 Herman Pressler, P.O. Box 20186
Houston TX 77225
E-mail: katherine.s.eggleston@uth.tmc.edu

Hosted in the Center for Research on Violence Against Women institutional repository with written permission from Mary Ann Liebert, publishers.

This article has been cited by:
1. Aya Kuwahara, Ribeka Takachi, Yoshitaka Tsubono, Shizuka Sasazuki, Manami Inoue, Shoichiro Tsugane. 2010. Socioeconomic
status and gastric cancer survival in Japan. Gastric Cancer 13:4, 222-230. [CrossRef]
2. Anne Marie McCarthy, Tamara Dumanovsky, Kala Visvanathan, Amy R. Kahn, Maria J. Schymura. 2010. Racial/ethnic and
socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995–2006. Cancer Causes
& Control 21:10, 1645-1655. [CrossRef]
3. Jessica L. Burris, Michael Andrykowski. 2010. Disparities in mental health between rural and nonrural cancer survivors: a
preliminary study. Psycho-Oncology 19:6, 637-645. [CrossRef]
4. Melissa McLeod, Ricci Harris, Gordon Purdie, Donna Cormack, Bridget Robson, Peter Sykes, Sue Crengle, Douglas Iupati, Nick
Walker. 2010. Improving survival disparities in cervical cancer between Māori and non-Māori women in New Zealand: a national
retrospective cohort study. Australian and New Zealand Journal of Public Health 34:2, 193-199. [CrossRef]
5. Ann L. Coker , Christopher P. DeSimone , Katherine S. Eggleston , Arica L. White , Melanie Williams . 2009. Ethnic Disparities
in Cervical Cancer Survival Among Texas WomenEthnic Disparities in Cervical Cancer Survival Among Texas Women. Journal
of Women's Health 18:10, 1577-1583. [Abstract] [Full Text] [PDF] [PDF Plus]
6. Naomi Brewer , Neil Pearce , Mona Jeffreys , Paul White , Lis Ellison-Loschmann . 2009. Demographic Differences in Stage at
Diagnosis and Cervical Cancer Survival in New Zealand, 1994–2005Demographic Differences in Stage at Diagnosis and Cervical
Cancer Survival in New Zealand, 1994–2005. Journal of Women's Health 18:7, 955-963. [Abstract] [PDF] [PDF Plus]
7. Kathleen F. Brookfield, Michael C. Cheung, Joseph Lucci, Lora E. Fleming, Leonidas G. Koniaris. 2009. Disparities in survival
among women with invasive cervical cancer. Cancer 115:1, 166-178. [CrossRef]
8. Vicki B. Benard, Christopher J. Johnson, Trevor D. Thompson, Katherine B. Roland, Sue Min Lai, Vilma Cokkinides, Florence
Tangka, Nikki A. Hawkins, Herschel Lawson, Hannah K. Weir. 2008. Examining the association between socioeconomic status
and potential human papillomavirus-associated cancers. Cancer 113:S10, 2910-2918. [CrossRef]
9. Sujana Movva, Anne-Michelle Noone, Mousumi Banerjee, Divya A. Patel, Kendra Schwartz, Cecilia L. Yee, Michael S. Simon.
2008. Racial differences in cervical cancer survival in the Detroit metropolitan area. Cancer 112:6, 1264-1271. [CrossRef]

Hosted in the Center for Research on Violence Against Women institutional repository with written permission from Mary Ann Liebert, publishers.

